Susquehanna International Group’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.02M Buy
75,989
+72,683
+2,199% +$7.3M ﹤0.01% 3657
2025
Q4
$338K Sell
3,306
-28,380
-90% -$2.54M ﹤0.01% 9672
2025
Q3
$1.98M Sell
31,686
-151,718
-83% -$8.25M ﹤0.01% 5819
2025
Q2
$9.54M Sell
183,404
-12,140
-6% -$542K ﹤0.01% 2897
2025
Q1
$8.33M Buy
195,544
+143,710
+277% +$6.2M ﹤0.01% 2778
2024
Q4
$1.58M Sell
51,834
-22,220
-30% -$625K ﹤0.01% 5827
2024
Q3
$1.7M Buy
+74,054
New +$2.1M ﹤0.01% 5620
2024
Q2
Sell
-223,585
Closed -$5.21M 12451
2024
Q1
$4.61M Buy
223,585
+68,740
+44% +$1.47M ﹤0.01% 3758
2023
Q4
$4.19M Sell
154,845
-38,086
-20% -$999K ﹤0.01% 4014
2023
Q3
$5.72M Buy
192,931
+51,782
+37% +$1.82M ﹤0.01% 3309
2023
Q2
$5.05M Sell
141,149
-203,533
-59% -$5.85M ﹤0.01% 3519
2023
Q1
$8.08M Buy
344,682
+195,496
+131% +$5.58M ﹤0.01% 2764
2022
Q4
$4.06M Buy
149,186
+104,660
+235% +$4.79M ﹤0.01% 3558
2022
Q3
$2.4M Sell
44,526
-86,270
-66% -$4.43M ﹤0.01% 4563
2022
Q2
$5.28M Buy
130,796
+92,569
+242% +$4.59M ﹤0.01% 3100
2022
Q1
$2.53M Sell
38,227
-7,208
-16% -$493K ﹤0.01% 4957
2021
Q4
$4.54M Buy
45,435
+42,754
+1,595% +$4.42M ﹤0.01% 3911
2021
Q3
$335K Buy
+2,681
New +$319K ﹤0.01% 10336
2021
Q2
Sell
-1,761
Closed -$237K 12797
2021
Q1
$269K Sell
1,761
-3,530
-67% -$534K ﹤0.01% 10830
2020
Q4
$682K Buy
5,291
+3,046
+136% +$350K ﹤0.01% 7610
2020
Q3
$251K Sell
2,245
-188,270
-99% -$17.2M ﹤0.01% 9057
2020
Q2
$15.5M Buy
190,515
+98,419
+107% +$7.93M ﹤0.01% 1672
2020
Q1
$6.41M Sell
92,096
-81,310
-47% -$6.24M ﹤0.01% 2258
2019
Q4
$13.6M Sell
173,406
-49,106
-22% -$3.54M ﹤0.01% 1785
2019
Q3
$14.2M Buy
222,512
+139,931
+169% +$12.3M ﹤0.01% 1628
2019
Q2
$7.13M Buy
82,581
+41,246
+100% +$3.15M ﹤0.01% 2275
2019
Q1
$3.17M Buy
+41,335
New +$2.29M ﹤0.01% 3050

Other funds holding GH

Susquehanna International Group's GH Position: Q1 2026 in Review

Susquehanna International Group increased its Guardant Health (GH) stake by 2,199% in Q1 2026, buying an estimated $7.3M and bringing the position to 75,989 shares worth $7.02M. The position accounts for ﹤0.01% of the portfolio, ranked #3657.

Susquehanna International Group first reported a position in GH in Q1 2019 and has held it in 27 quarters since. The position peaked at $15.5M in Q2 2020. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • Susquehanna International Group held 75,989 shares of Guardant Health worth $7.02M as of Q1 2026.
  • Susquehanna International Group bought 72,683 Guardant Health shares in Q1 2026, an estimated $7.3M.
  • Guardant Health made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #3657 holding.
  • Susquehanna International Group first reported a position in Guardant Health in Q1 2019 and has held it in 27 quarters since.
  • Susquehanna International Group's Guardant Health position peaked at $15.5M in Q2 2020.
  • 481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.